Poland· PL-100252738
Tepadina
A thiotepa product containing thiotepum, registered in Poland by ADIENNE S.r.l. S.U.. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Thiotepa is registered in 16 of 19 countries.
Countries holding a registration under ATC L01AC01 (thiotepa), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Thiotepa · ATC L01AC01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Thiotepum
- Manufacturer
- ADIENNE S.r.l. S.U.
- Country
- Poland (PL)
- ATC code
- L01AC01
- ATC class
- Thiotepa
- Defined daily dose
- 1.62 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990893553
- gtin08051739320138
- gtin08051739320190
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
202 interactions on record for thiotepa.
Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Thiotepa · interactions on record
202 records
- 43 severe
- 105 moderate
- 14 minor
- 40 info
Most severe, free to view
- Nalidixic acidJ01MB02severe
- CyclophosphamideL01AA01severe
- ChlorambucilL01AA02severe
- MelphalanL01AA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Thiotepa in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTEPADINAADIENNE S.r.l. S.U.
- SpainTEPADINA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONAdienne S.R.L.
- SwedenTEPADINA 100 mg Pulver till koncentrat till infusionsvätska, lösningADIENNE S.r.l.
- United KingdomTepadina 100mg powder for concentrate for solution for infusion vialsAdienne Pharma & Biotech
- CzechiaTEPADINAADIENNE S.r.l., Caponago
- BelgiumTepadina 100 mgAdienne
- IrelandTEPADINA 100 mg powder for concentrate for solution for infusionAdienne S.r.l.
- IcelandTepadinaADIENNE S.r.l.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Thiotepa Fresenius Kabi
- Belgium · Thiotepa Fresenius Kabi
- Bulgaria · Тиотепа Msn
- Czechia · Thiotepa Fresenius Kabi, Thiotepa Msn
- Germany · Thionovia, Thiotepa Fresenius Kabi
- Denmark · Thiotepa Abcur, Thiotepa Fresenius Kabi
- Estonia · Thiotepa Fresenius Kabi, Thiotepa Msn
- Spain · Thionovia, Thiotepa Vivanta
- Finland · Thiotepa Abcur, Thiotepa Fresenius Kabi
- France · Thionovia, Thiotepa Fresenius Kabi
- United Kingdom (Northern Ireland) · Thiotepa, Thiotepa Hikma Farmacêutica (Portugal)
- Croatia · Tiotepa Fresenius Kabi, Tiotepa Msn
- Hungary · Thiotepa, Thiotepa Medac
- Ireland · Thiotepa Fresenius Kabi
- Iceland · Tepadina, Thiotepa Abcur
- Italy · Thionovia, Thiotepa Medac
- Liechtenstein · Tepadina, Thiotepa Riemser
- Lithuania · Thiotepa Fresenius Kabi, Thiotepa Msn
- Latvia · Thiotepa Fresenius Kabi, Thiotepa Msn
- Netherlands · Thiotepa Fresenius Kabi, Thiotepa Medac
- Norway · Tepadina, Thiotepa Abcur
- Portugal · Tiotepa Fresenius Kabi, Tiotepa Hikma
- Romania · Thiotepa Fresenius Kabi, Thiotepa Msn
- Sweden · Thionovia, Thiotepa Abcur
- Slovenia · Thiotepa Msn
- Slovakia · Thiotepa Fresenius Kabi, Thiotepa Msn
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a1bb8887-b980-4d16-9ddb-911187b52bc9 GET /v1/drugs/a1bb8887-b980-4d16-9ddb-911187b52bc9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "100 mg",
"packaging": "05909990893553 ¦ Rpz ¦ Skasowane ¦ EU/1/10/622/002 ¦ 68599\n1 fiol. proszku\n08051739320138 ¦ Rpz ¦ Skasowane ¦ EU/1/10/622/002 ¦ 133657\n1 fiol. proszku\n08051739320190 ¦ Rpz ¦ EU/1/10/622/002 ¦ 152846\n1 fiol. proszku",
"substance": "Thiotepum 100 mg",
"common_name": "Thiotepum",
"pl_product_id": "100252738",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about thiotepa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.